These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16234714)

  • 1. Chronic inflammation from polycarbonate motility peg inhibits osteogenesis in a human hydroxyapatite orbital implant.
    Thakker MM; Zhang J; Sires BS
    Ophthalmic Plast Reconstr Surg; 2005 Sep; 21(5):399-401. PubMed ID: 16234714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of pegged and non-pegged hydroxyapatite orbital implants.
    Fahim DK; Frueh BR; Musch DC; Nelson CC
    Ophthalmic Plast Reconstr Surg; 2007; 23(3):206-10. PubMed ID: 17519658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteogenesis in a human hydroxyapatite orbital implant 5.5 years after implantation.
    Sires BS; Benda PM
    Am J Ophthalmol; 2000 Sep; 130(3):368-9. PubMed ID: 11020425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic analysis of 15 explanted hydroxyapatite implants.
    Jordan DR; Brownstein S; Faraji H
    Ophthalmic Plast Reconstr Surg; 2004 Jul; 20(4):285-90. PubMed ID: 15266142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of motility peg placement for porous hydroxyapatite orbital implants.
    Lin CJ; Liao SL; Jou JR; Kao SC; Hou PK; Chen MS
    Br J Ophthalmol; 2002 Apr; 86(4):394-6. PubMed ID: 11914206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic exposure of hydroxyapatite orbital implants: cilia implantation and epithelial downgrowth.
    Kim JW; Kikkawa DO; Aboy A; Glasgow BJ
    Ophthalmic Plast Reconstr Surg; 2000 May; 16(3):216-22. PubMed ID: 10826763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications associated with pegging hydroxyapatite orbital implants.
    Jordan DR; Chan S; Mawn L; Gilberg S; Dean T; Brownstein S; Hill VE
    Ophthalmology; 1999 Mar; 106(3):505-12. PubMed ID: 10080206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory mass formation secondary to hydroxyapatite orbital implant leakage.
    Chee E; Kim YD; Woo KI; Lee JH; Kim JH; Suh YL
    Ophthalmic Plast Reconstr Surg; 2013; 29(2):e40-2. PubMed ID: 23250330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrovascular ingrowth into hydroxyapatite and porous polyethylene orbital implants wrapped with acellular dermis.
    Thakker MM; Fay AM; Pieroth L; Rubin PA
    Ophthalmic Plast Reconstr Surg; 2004 Sep; 20(5):368-73. PubMed ID: 15377904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of hydroxyapatite pegging: comparison between polycarbonate and titanium peg system.
    Salour H; Eshaghi M; Abrishami M; Bagheri A; Aletaha M
    Eur J Ophthalmol; 2007; 17(3):408-12. PubMed ID: 17534825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coralline hydroxyapatite orbital implant (bio-eye): experience with 158 patients.
    Jordan DR; Gilberg S; Bawazeer A
    Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):69-74. PubMed ID: 14752315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine hydroxyapatite orbital implant: a preliminary report.
    Perry JD; Goldberg RA; McCann JD; Shorr N; Engstrom R; Tong J
    Ophthalmic Plast Reconstr Surg; 2002 Jul; 18(4):268-74. PubMed ID: 12142759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteogenesis with hematopoiesis simulating infection in a hydroxyapatite orbital implant.
    Jordan DR; Belliveau MJ; Brownstein S; Padmore RF
    Ophthalmic Plast Reconstr Surg; 2009; 25(1):72-4. PubMed ID: 19273939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Culture-proven Aspergillus fumigatus infection in a primary hydroxyapatite orbital implant.
    Sharma NS; Ooi JL; Maloof TC; Wilcsek G; Francis IC; Coroneo MT
    Clin Exp Ophthalmol; 2007 Apr; 35(3):294-5. PubMed ID: 17430526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histopathologic review of 18 explanted porous polyethylene orbital implants.
    Chuo JY; Dolman PJ; Ng TL; Buffam FV; White VA
    Ophthalmology; 2009 Feb; 116(2):349-54. PubMed ID: 19091412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications in motility PEG placement for hydroxyapatite orbital implant in anophthalmic socket.
    Lee SY; Jang JW; Lew H; Kim SJ; Kim HY
    Jpn J Ophthalmol; 2002; 46(1):103-7. PubMed ID: 11853724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel approach to re-pegging hydroxyapatite implants using bioactive glass.
    Heringer DM; Ng JD
    Ophthalmic Plast Reconstr Surg; 2006; 22(1):45-7. PubMed ID: 16418665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrovascularization of intraorbital hydroxyapatite-coated alumina sphere in rabbits.
    Chung WS; Song SJ; Lee SH; Kim EA
    Korean J Ophthalmol; 2005 Mar; 19(1):9-17. PubMed ID: 15929481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases.
    Yoon JS; Lew H; Kim SJ; Lee SY
    Ophthalmology; 2008 Mar; 115(3):566-572.e2. PubMed ID: 17854900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late infection of hydroxyapatite orbital implants.
    Sloan BH; McNab AA; McKelvie P
    Aust N Z J Ophthalmol; 1999 Feb; 27(1):45-8. PubMed ID: 10080337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.